← FDA Drug Approvals (Drugs@FDA)
IMPAVIDO
NDA · New Drug Application · Sponsor: KNIGHT THERAPS · Approved 2014-03-19
Drug application
- FDA Application #
NDA204684- Application type
- New Drug Application
- Brand name
- IMPAVIDO
- Generic name
- MILTEFOSINE
- Active ingredients
- MILTEFOSINE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- KNIGHT THERAPS
- Manufacturer
- Profounda, Inc.
- First approval
- 2014-03-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown